AlgaeCytes key facts
as of Oct 2026- Operator of a biotechnology company intended to offer health-promoting ingredients from algae.
- AlgaeCytes is valued at approximately $84.3M as of Oct 2026 (last reported valuation).
- It has raised $28.1M; the latest was Later Stage VC ($4.3M) in Dec 2025.
- Notable investors include Innovate UK, Bundesministerium für Wirtschaft und Klimaschutz, BioProNET, IBG Beteiligungsgesellschaft Sachsen-Anhalt.
- Status: Privately Held (backing).
AlgaeCytes's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch AlgaeCytes: the Monday email on marks, rounds and moves
AlgaeCytes funding rounds
No funding rounds for AlgaeCytes are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
AlgaeCytes valuation
AlgaeCytes's last reported valuation was $84.3 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
AlgaeCytes investors
4 investors are on record for AlgaeCytes, including Innovate UK, Bundesministerium für Wirtschaft und Klimaschutz, BioProNET and IBG Beteiligungsgesellschaft Sachsen-Anhalt.
About AlgaeCytes
Operator of a biotechnology company intended to offer health-promoting ingredients from algae. The company specializes in the production of omega oils and bio-actives from freshwater algae for healthcare, personal care, and nutraceutical markets, while reducing the reliance on limited fish stock for protein and oil supplements, enabling vegan consumers to avail of enhanced and organic products.
- Sector
- Materials and Resources
- HQ
- Kent, United Kingdom
- Founded
- 2010
- Employees
- 12
- Website
- algaecytes.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.